Amoeba SA (FR:ALMIB) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Amoéba has achieved a significant milestone with the European Food Safety Authority’s (EFSA) approval of its biocontrol active substance, recognized for its efficacy and low-risk profile. This breakthrough, along with a partnership with biocontrol leader Koppert, positions Amoéba to launch its innovative biofungicide solution, AXPERA, marking a pivotal shift towards becoming a commercial and industrial entity by 2025. The company is now preparing to seek marketing authorization across eight European countries, with a decision anticipated next year.
For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.